Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC).

ABSTRACT:

SUBMITTER: Boschi C 

PROVIDER: S-EPMC9402686 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature